87 related articles for article (PubMed ID: 2408060)
21. Autologous bone marrow transplantation for myeloma patients using PNA- and CD19-purged marrow rescue.
Rhodes EG; Baker PK; Rhodes JM; Davies JM; Duguid JK
Bone Marrow Transplant; 1994 Jun; 13(6):795-9. PubMed ID: 7522727
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse.
Soiffer RJ; Roy DC; Gonin R; Murray C; Anderson KC; Freedman AS; Rabinowe SN; Robertson MJ; Spector N; Pesek K
Bone Marrow Transplant; 1993 Sep; 12(3):243-51. PubMed ID: 8241984
[TBL] [Abstract][Full Text] [Related]
23. Vim-2, candidate monoclonal antibody for purging autologous marrow grafts in acute myeloblastic leukaemia.
Delwel R; Bot F; Knapp W; Löwenberg B
Bone Marrow Transplant; 1987 Aug; 2(2):149-54. PubMed ID: 3332163
[TBL] [Abstract][Full Text] [Related]
24. Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement.
Grañena A; Castellsagué X; Badell I; Ferra C; Ortega J; Brunet S; Puntí C; Sureda A; Picón M; Valls A; Rutllant M; García J
Bone Marrow Transplant; 1999 Sep; 24(6):621-7. PubMed ID: 10490727
[TBL] [Abstract][Full Text] [Related]
25. BP-3 alloantigen. A cell surface glycoprotein that marks early B lineage cells and mature myeloid lineage cells in mice.
McNagny KM; Cazenave PA; Cooper MD
J Immunol; 1988 Oct; 141(8):2551-6. PubMed ID: 3262662
[TBL] [Abstract][Full Text] [Related]
26. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
Ciudad J; Orfao A; Vidriales B; Macedo A; Martínez A; González M; López-Berges MC; Valverde B; San Miguel JF
Haematologica; 1998 Dec; 83(12):1069-75. PubMed ID: 9949623
[TBL] [Abstract][Full Text] [Related]
27. Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement.
Morishima Y; Miyamura K; Kojima S; Ueda R; Morishita Y; Sao H; Tanimoto M; Ohno R; Sobue R; Hirano M
Bone Marrow Transplant; 1993 Apr; 11(4):255-9. PubMed ID: 7683550
[TBL] [Abstract][Full Text] [Related]
28. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction.
Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H
Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022
[TBL] [Abstract][Full Text] [Related]
29. Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia.
Zetterquist H; Mattsson J; Uzunel M; Näsman-Björk I; Svenberg P; Tammik L; Bayat G; Winiarski J; Ringdén O
Bone Marrow Transplant; 2000 Apr; 25(8):843-51. PubMed ID: 10808205
[TBL] [Abstract][Full Text] [Related]
30. Autologous bone marrow transplantation for leukemia.
Stuart RK
Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
[TBL] [Abstract][Full Text] [Related]
31. Leukaemia-associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: detection in remission marrow predicts outcome.
Griesinger F; Pirò-Noack M; Kaib N; Falk M; Renziehausen A; Troff C; Grove D; Schnittger S; Büchner T; Ritter J; Hiddemann W; Wörmann B
Br J Haematol; 1999 Apr; 105(1):241-55. PubMed ID: 10233388
[TBL] [Abstract][Full Text] [Related]
32. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma.
Kimlinger T; Witzig TE
Bone Marrow Transplant; 1997 Mar; 19(6):553-6. PubMed ID: 9085734
[TBL] [Abstract][Full Text] [Related]
33. Selective T cell depletion of donor allogeneic marrow with anti-CD6 monoclonal antibody: rationale and results.
Soiffer RJ; Ritz J
Bone Marrow Transplant; 1993; 12 Suppl 3():S7-10. PubMed ID: 8124262
[TBL] [Abstract][Full Text] [Related]
34. Characterization of hemopoietic cell populations from human cord blood expressing c-kit.
Reisbach G; Bartke I; Kempkes B; Kostka G; Ellwart J; Birner A; Thalmeier K; Mailhammer R; Bornkamm GW; Ullrich A
Exp Hematol; 1993 Jan; 21(1):74-9. PubMed ID: 7678090
[TBL] [Abstract][Full Text] [Related]
35. [In vitro manipulation of bone marrow cells for bone marrow transplantation].
Morishima Y
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3034-43. PubMed ID: 3056275
[TBL] [Abstract][Full Text] [Related]
36. Autologous bone marrow transplantation for acute lymphoblastic leukemia: role of bone marrow purging.
Canals C; Picón M; Sanchez T; Torrico C; Amill B; Tugues D; Sierra J; Grañena A; Badell I; Brunet S
Prog Clin Biol Res; 1994; 389():125-32. PubMed ID: 7700894
[No Abstract] [Full Text] [Related]
37. Myeloid lineage involvement in acute lymphoblastic leukemia: a morphology antibody chromosomes (MAC) study.
Larramendy M; el-Rifai W; Saarinen U; Alitalo R; Luomahaara S; Knuutila S
Exp Hematol; 1995 Dec; 23(14):1563-7. PubMed ID: 8542947
[TBL] [Abstract][Full Text] [Related]
38. Functional and phenotypic upregulation of CD13/aminopeptidase-N on precursor-B acute lymphoblastic leukemia after in vitro stimulation.
Makrynikola V; Favaloro EJ; Browning T; Bianchi A; Bradstock KF
Exp Hematol; 1995 Oct; 23(11):1173-9. PubMed ID: 7556527
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic heterogeneity of TDT+ cells in the blood and bone marrow: implications for surveillance of residual leukemia.
Smith RG; Kitchens RL
Blood; 1989 Jul; 74(1):312-9. PubMed ID: 2473798
[TBL] [Abstract][Full Text] [Related]
40. The use of immunorosettes for purging of bone marrow in childhood cancer.
Slaper-Cortenbach IC; Wijngaarden-du Bois MJ; Admiraal LG; Tetteroo PA; Figdor CG; van Leeuwen EF
Prog Clin Biol Res; 1990; 333():337-44. PubMed ID: 2308990
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
